Atopic dermatitis, a chronic skin condition affecting millions worldwide, often leaves sufferers searching for effective treatments with minimal side effects. A Finnish biotech startup, Uute Scientific, in collaboration with the University of Helsinki and Tampere University, has conducted a study suggesting a promising alternative. The research explores the potential of Re-Connecting Nature™ (RCN), a microbial extract mimicking the biodiversity of Finnish forests, as a supportive treatment. This study offers hope for those seeking nature-based solutions for atopic skin conditions, emphasizing the importance of natural microbial exposure in managing such ailments.
In earlier reports, the potential of natural microbial exposure in managing skin conditions has been a topic of interest. Previous studies have highlighted the importance of microbial diversity in maintaining skin and immune health, particularly in urban environments, where individuals are less exposed to natural settings. Uute Scientific’s recent findings build upon this knowledge, offering empirical evidence that supports the hypothesis that microbial exposure can aid in managing atopic dermatitis. Incorporating such knowledge into consumer products represents an innovative approach to dermatological treatment.
What Did the Study Involve?
The study engaged 142 participants diagnosed with atopic dermatitis, dividing them into two groups. One group used a placebo lotion, while the other applied a lotion containing the RCN extract over seven months. Researchers monitored the participants’ skin conditions and medication usage, aiming to evaluate the microbial extract’s efficacy in improving skin health. This study was conducted as part of academic dissertations at two prominent Finnish universities, ensuring rigorous scientific methodology.
How Effective is the Microbial Extract?
Results demonstrated a notable reduction in atopy medication use among the microbial extract group compared to the placebo group. Additionally, the RCN lotion enhanced the skin’s protective barrier, a critical factor in managing atopic dermatitis. The research suggests that the microbial extract could supplement existing treatments, offering an alternative for individuals dependent on medications with undesirable side effects. These findings highlight the extract’s potential in supporting immune function and mitigating skin irritation.
Uute Scientific’s CEO, Kari Sinivuori, emphasized the broader implications of the study:
“This is truly a historic study that shows scientific evidence of the power of our nature’s microbes to help with severe disease. We start with atopic skin, but other immune-mediated diseases, such as different allergies, asthma, Parkinson’s disease, or Alzheimer’s, are also likely to benefit from this.”
The study underscores the possibility of leveraging nature’s microbial diversity in tackling immune-mediated conditions, encouraging further exploration in this area.
RCN is already incorporated into numerous beauty and health products globally, used by brands such as NOBE, Luonkos, Moi Forest, Sees, and Doggy Potion. Its successful application in skin care products could pave the way for its inclusion in dermatological treatments, providing a natural alternative for those with skin sensitivities.
This study represents a significant step forward in dermatological research by showcasing the potential benefits of natural microbial exposure for managing atopic dermatitis. While the RCN extract has demonstrated promise in initial studies, further research is essential to confirm these findings and explore its broader applications. As the understanding of the human microbiome and its relationship with health conditions grows, innovative solutions like RCN may offer new avenues for treatment. For individuals with atopic dermatitis, this could mean improved quality of life and reduced reliance on traditional medications.
